SPHK1 and familial pancreatic carcinoma: To further explore the roles of SPHK1 and HAS2 in pancreatic cancer, a preliminary analysis was performed to identify whether the expression of SPHK1 and HAS2 in pancreatic cancer tissues was associated with clinicopathological parameters.